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Background. Even though health professionals (HPs) need special consideration for hepatitis B virus (HBV) vaccination, this is
not widely implemented in low- and middle-income countries. The aim of this study was to determine the vaccination status
of health professionals against hepatitis B virus infection, to identify barriers to vaccination and to identify factors associated
with vaccination status. Methods. This cross-sectional study was conducted from June 1 to 15, 2016. Data was collected using self-
administered questionnaire and analysed using SPSS version 21. A test of associationwas done using binary logistic regression and P
value less than 0.05 was considered statistically significant. Results. Out of 286 HPs included in the study 28.7% received full course
vaccination against HBV. The most frequently mentioned reasons for not being vaccinated against HBV are unavailability of the
vaccine (58.2%) and its cost (18.5%). Age, marital status, level of education, and type of profession have significant association with
vaccination status. Conclusion. HBV coverage among HPs in Gondar University Hospital (GUH) is inadequate. This is mostly due
to unavailability of the vaccine and its cost. Vaccination status significantly varies based on level of education, type of profession,
age, and marital status. We recommend making vaccines available and accessible.
1. Introduction
Hepatitis B virus (HBV) is highly infectious and causes
serious health problems. Worldwide, approximately 2 billion
people have been infected with HBV. Of these, 240 million
are chronically infected persons with a varying prevalence
geographically, highest in Africa and Asia [1, 2]. The major
complications of chronic Hepatitis B virus are cirrhosis and
hepatocellular carcinoma. An estimated 650,000 people die
annually due to chronic Hepatitis B virus infection [3].
HBV is spread primarily by percutaneous or mucosal
contact to infected blood and a number of body fluids,
including saliva, menstrual, vaginal, and seminal fluids [4].
Transmission of the virus may also result from accidental
inoculation of minute amounts of blood or fluid during
medical, surgical, and dental procedures or from razors
and similar objects contaminated with infected blood; use
of inadequately sterilized syringes and needles; intravenous
and percutaneous drug abuse; tattooing; body piercing; and
acupuncture [3].
Health care providers are at high risk for hepatitis B
virus (HBV) infection [5]. The virus remains infectious for
prolonged periods on environmental surfaces and is trans-
missible in the absence of visible blood. Health care providers
do not recognize all exposures to potentially infectious blood
or body fluids.Health care providers had a prevalence ofHBV
infection approximately 10 times greater than the general
population [6]. The WHO report showed that about 6% of
HCPs are each year exposed to blood-borne HBV infections
corresponding to about 66,000HBV infections in health care
workers worldwide [7].
Even though there are infection control practices and
administration of hepatitis B immune globulin following
suspected exposure to reduce the risk of HBV transmission,
none have been as effective as active immunization with
hepatitis B vaccine, which remains the single most important
hepatitis B prevention measure [8, 9].
There is a need to vaccinate all health care providers
as a matter of policy and provide postexposure prophylaxis
after having significant exposure to patient’s blood [10]. Even
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though health care providers need special consideration for
HBV screening and HBV vaccination, this is not widely
implemented in low- and middle-income countries [3, 5]. It
is the lack of awareness and not giving sufficient attention on
part of health care providers coupled with the negligence of
the risk that has led them being incompletely vaccinated [11].
The aim of this study was to determine the vaccination status
of health professionals against hepatitis B virus infection, to
identify barriers for unvaccination, and to identify factors
associated with vaccination status.
2. Methods
2.1. Study Area and Period. This study was done at Gondar
University Hospital, Gondar, Ethiopia. Gondar is found
in north western Ethiopia, 727 km away from the capital,
Addis Ababa. Gondar University Hospital provides service in
different departments like gynecology, pediatrics, dentistry,
ophthalmology, psychiatry, dermatology, surgery, pharmacy,
medical laboratory, and others. It has more than 460 beds.
Currently there are 950 health care professionals working in
the hospital. The study was conducted from June 1 to June 15,
2016.
2.2. Study Design and Subjects. Cross-sectional study design
was employed to assess the vaccination status of health
professionals against hepatitis B virus infection. All health
professionals that were present at work during the study
period were considered for the study. Health professionals
who were not voluntary to participate were excluded. Sample
size was calculated using single population proportion for-
mula assuming the prevalence of HBV vaccination among
health professionals as 50% in order to get larger sample size.
Correction formula was used because the source population
was less than 10,000. Finally 286 HPs were included in
the study. Study participants were selected by using simple
random sampling technique/lottery method from the list of
health works available during the study period.
2.3. Data Collection and Management. Structured data col-
lection format was developed by the research authors after
reviewing literatures done on the topic in various parts
of the world [12–14]. The data collection tool consists
of participant’s sociodemographic characteristics, questions
that measure vaccination status of participants, and barriers
for vaccination. In order to check any inconsistency the
data collection tool was pretested on 5% of the sample
population and necessary adjustments were done before the
actual period of data collection. Data collection was done
by two graduating pharmacy students by distributing self-
administered questionnaire prepared in English language to
the participants and recollecting it.The principal investigator
cheeked the completeness, consistency, and accuracy of the
collected data every day.
2.4. Data Analysis. Data was coded and entered into the
Epinfo (version 7) software. Then, data was exported to SPSS
(version 21) for analysis. Descriptive statistics was done and
results were presented in tables. A test of associationwas done
using binary logistic regression. All the statistical tests were
significant at 𝑃 value less than 0.05.
2.5. Ethical Consideration. Ethical clearance was obtained
from the Ethical Review Committee of School of Pharmacy,
University of Gondar. Medical director of the hospital and
other concerned officials were communicated and permis-
sion was granted. The respondents were informed about the
purpose of the study. Confidentiality of the information taken
was assured; thus the name and address of the participants
were not recorded in the data collection format.
3. Results
3.1. Sociodemographic Characteristics of Health Professionals.
As shown in Table 1 out of 286HPs included in the study,
186 (55.6%) were males. Majority of HPs (82.9%) were in
the age group of 21–29 years and mean age of the HPs was
26.91 ± 4.57 years (range 21–58). About two-thirds (67.1%)
were unmarried and more than three-fourths (76.9%) were
orthodox religion followers. Most of the HPs were nurses
(32.9%) and medical doctors (31.8%). About three-fourths
(75.2%) of theHPs had less than five years of work experience.
As indicated in Table 2 more than half (51%) of health
professionals have never received hepatitis B vaccine. From
health professionals who received the vaccine only 82 (58.6%)
received the full course of the vaccine. Overall percentage of
HPs inGUHwho receive full course vaccination againstHBV
is 28.7%.
The most frequently mentioned reasons for not being
vaccinated against HBV are unavailability of the vaccine
(58.2%) and its cost (18.5%). Being busy is the common reason
(32.8%) for not receiving full course of vaccination. As shown
in Table 3 about one-fourth (25.9%) of the study participants
started the vaccination and wait for the next dose.
The result ofmultivariate binary logistic regression analy-
sis showed that age,marital status, level of education, and type
of profession have significant association with vaccination
status.
As indicated in Table 4 unmarried health professionals,
first degree holders, master degree holders, medical doctors,
and pharmacists have better vaccination status than others.
Professionals with age of 30–39 years have 11.1 times lower
vaccination status than those health professionals with age 40
years and above.
As shown in Table 5 from all of the sociodemographic
characteristics of health professionals only the type of pro-
fession has significant association with completion of the
full course of HBV vaccination. Accordingly laboratory
technologists are 12.5 times less likely to complete their HBV
vaccination.
4. Discussion
Although hepatitis B is preventable disease it is one of the
major causes of morbidity and mortality throughout the
world including Ethiopia. Prevention is ultimately the most
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Table 1: Sociodemographic characteristics of health professionals,
GUH, Ethiopia, 2016.
Characteristics Frequency (n) Percentage (%)
Sex
Male 181 63.3
Female 105 36.7
Age (yrs)
21–29 237 82.9
30–39 41 14.3
>40 8 2.8
Religion
Orthodox Christians 220 76.9
Muslim 28 9.8
Protestant Christians 29 10.1
Othersa 9 3.1
Marital status
Unmarried 192 67.1
Married 94 32.9
Education level
Certificate 6 2.1
Diploma 9 3.1
First degree 241 84.3
Master degree 21 7.3
Specialist 9 3.1
Profession
Medical doctors 91 31.8
Nurses 94 32.9
Health officers 6 2.1
Pharmacist 34 11.9
Lab. technologists 26 9.1
Midwives 20 7
Othersb 15 5.2
Work experience
<5 years 215 75.2
≥5 years 71 24.8
Department
Surgical department 35 12.2
Laboratory 28 9.8
Delivery unit 27 9.4
Emergency department 15 5.2
Internal medicine 75 26.2
Pediatrics 53 18.5
Pharmacy unit 15 5.2
Gynecology/obstetrics 13 4.5
Othersc 25 8.7
aCatholic, atheist, and Hindu; bhealth officer, anesthesia, dentist, physio-
therapies, and psychiatry nurse; cdental department, oncology, optometry,
psychiatry ward, recovery, and general ward.
efficient means towards improved health [15]. Immunization
programs are highly effective and clearly protect populations
and individuals at risk if they are properly implemented
[16]. According to WHO estimate, hepatitis B vaccination
Table 2: Vaccination status of health professionals against HBV in-
fection, GUH, Ethiopia, 2016.
Characteristics Frequency
(𝑛)
Percentage
(%)
Ever received hepatitis B vaccination 140 49
Never received hepatitis B vaccination 146 51
total 286 100
Received full doses of vaccine 82 58.6
Did not receive full doses of vaccine 58 41.4
Total 140 100
coverage among health care workers varies from 18% being
lowest in Africa to highest 77% in Australia andNew Zealand
[7].
In this study less than half (49%) of health professionals
working in Gondar University Hospital were received hepati-
tis B virus vaccination. A very similar result was reported in
studies conducted in Burkina Faso, Japan, and India which
indicated vaccination coverage of 47.7%, 48.2%, and 51.2%,
respectively [17–19]. But this is lower vaccination coverage
as compared to what was reported in studies conducted
in Nigeria (91.9%), Sweden (79%), Pakistan (76%), and
India (79.7 and 70.3%) [20–24]. The fact that most of the
respondents in the current study were young and had fewer
years of practice may be responsible for the low rate of
vaccination as it is found in this study that younger age is
significantly associated with unvaccination.
From those health professionals who reported that they
are vaccinated only 58.6% of them received the full course
of the vaccine. Overall only 28.7% of the health professionals
in GUH have received full dose of HBV vaccine. This is
a lower level of complete vaccination when compared with
the results of other previous studies. Studies conducted in
USA and France reported that 75% and 93% of health care
workers were completely vaccinated [22, 23]. There are also
several studies that reported around half (46.2%–57.6%) of
health care workers were completely vaccinated for HBV
[19, 23–26]. The lowest rate of complete vaccination in this
study therefore means that health professionals should not
only be encouraged to receive hepatitis B vaccine but also be
encouraged to complete the dose to ensure the effectiveness of
this vaccine.Thosewith incomplete vaccination status should
also be encouraged to have antihepatitis B titers measured to
determine their level of protection and if there will be a need
for a further dose of the vaccine.
For health professionals who did not take the vaccine, the
frequently stated reasons were unavailability of the vaccine
and its price each comprising 58.2% and 18.5%, respectively.
Similarly unavailability of the vaccine is mentioned in differ-
ent studies as one of themain reasons for not being vaccinated
[12, 19, 21, 27]. Studies conducted in Bahir Dar, Iran, and
Addis Ababa also indicated that the cost of the vaccine was
a barrier for vaccination in addition to vaccine unavailability
[12, 19, 27].
Being busy is the common reason (32.8%) for not com-
pleting the vaccination. In line with this Chaudhari et al.
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Table 3: Reasons for not being vaccinated against HBV and for not taking full course of the vaccine, GUH, Ethiopia, 2016.
Reasons Frequency (𝑛) Percentage (%)
Reason for not being vaccinated
(𝑛 = 146)
Cost of the vaccine 27 18.5
The vaccine is not easily available 85 58.2
Afraid of vaccine side effect 3 2.1
Vaccination is not necessary 2 1.4
Lack of information 12 8.2
Too busy 12 8.2
Afraid of needles 1 0.7
Othersd 4 2.7
Reason for not receiving full
course of vaccination (𝑛 = 58)
Fear of adverse effect 10 17.2
Assuming that it was enough 2 3.4
Being busy 19 32.8
Not available 8 13.8
Carelessness 4 6.9
Started and waited 15 25.9
dHBV positive, carelessness, and not useful.
reported that absence during vaccine drive due to leave or
temporary duty was one of the most common reasons for
not completing primary immunization in partially vaccinated
health care workers [28]. In the current study about one-
fourth (25.9%) of partially vaccinated health professionals
were on waiting for the next dose. According to the study
done in selected public hospitals of Addis Ababa for study
participants who did not complete the vaccine series, all of
them said that they were on wait for the last dose [12].
The findings of this study revealed that the type of
profession, level of education, participants age, and marital
status have significant association with vaccination status.
Significantly higher vaccination coverage was found for
medical doctors, pharmacists, first degree holders, master
degree holders, andunmarried health professionals than their
equivalents in the group. The presence of significant associa-
tion between type of profession and vaccination status is also
reported by somany studies [12, 13, 25, 28, 29].The study done
by Kathy et al. reported that more than high school education
has significantly higher vaccination coverage [14]. Younger
health professionals have less vaccination coverage than those
who are forty years old and above. This may be due to young
professionals stay in the institution is relatively less and have
less chance of getting vaccination campaign programmes
as compared to those who stayed longer in the institution.
Similarly Olubuyide et al. in a study among Nigerian doctors
and dentists reported that unvaccinated personnel weremore
likely to be surgeons or dentists less than 37 years of age
[30].
5. Limitation
The result of the study cannot be generalized as it is a single
centered study. Vaccination status was self-reported and not
verified by vaccination records. So recall bias could have led
to over- or underestimation of coverage.
6. Conclusion
We observed a generally low rate of HBV vaccine coverage
among health professionals in Gondar University Hospital.
Vaccination status significantly varies based on level of educa-
tion, type of profession, age, andmarital status. Unavailability
and cost of the vaccine were the major barriers for unvacci-
nation. Continued efforts are needed to increase the vaccine
coverage among unvaccinated health professionals to protect
workers and patients.
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Table 4: Factors associated with the HBV vaccination status of health professionals in GUH, Ethiopia, 2016.
Characteristics Yes (%) No (%) COR (95% CI) AOR (95% CI)
Sex
Male 74 (52.9%) 107 (73.3%) 2.45 (1.49–4.01)∗ 1.07 (0.52–2.18)
Female 66 (47.1%) 39 (26.7%) 1.00 1.00
Age (yrs)
21–29 107 (76.4%) 130 (89%) 0.73 (0.17–3.12) 0.22 (0.03–1.45)
30–39 30 (21.4%) 11 (7.5%) 0.22 (0.05–1.08) 0.09 (0.01–0.65)∗
≥40 3 (2.1%) 5 (3.4%) 1.00 1.00
Religion
Orthodox 109 (77.9%) 111 (76.0%) 0.51 (0.12–2.09) 0.29 (0.05–1.81)
Muslim 16 (11.4%) 12 (8.2%) 0.38 (0.08–1.81) 0.24 (0.03–1.77)
Protestant 12 (8.6%) 17 (11.6%) 0.71 (0.15–3.41) 0.21 (0.03–1.66)
Othersa 3 (2.1%) 6 (4.1%) 1.00 1.00
Marital status
Unmarried 72 (51.4%) 120 (82.2%) 4.36 (2.55–7.47)∗ 2.93 (1.34–6.44)∗
Married 68 (48.6%) 26 (17.8%) 1.00 1.00
Education level
Certificate 4 (2.9%) 2 (1.4%) 0.63 (0.07–5.35) 4.20 (0.28–62.67)
Diploma 4 (2.9%) 5 (3.4%) 1.56 (0.24–10.03) 8.25 (0.63–107.90)
First degree 114 (81.4%) 127 (87.0%) 1.39 (0.37–5.31) 7.61 (1.18–49.26)∗
Master degree 13 (9.3%) 8 (5.5%) 0.77 (0.18–3.74) 11.59 (1.34–100.48)∗
Specialist 5 (3.6%) 4 (2.7%) 1.00 1.00
Profession
Medical doctor 15 (10.7%) 76 (52.1%) 13.93 (3.91–49.68)∗ 20.60 (3.38–125.68)∗
Nurse 62 (44.3%) 32 (21.9%) 1.42 (0.42–4.81) 1.83 (0.34–9.68)
Health officer 4 (2.9%) 2 (1.4%) 1.38 (0.18–10.65) 1.59 (0.13–18.86)
Pharmacist 15 (10.7%) 19 (13.0%) 3.48 (0.92–13.17) 9.64 (1.43–65.17)∗
Lab. technologist 22 (15.7%) 4 (2.7%) 0.50 (0.11–2.39) 0.00
Midwifes 11 (7.9%) 9 (6.2%) 2.25 (0.53–9.54) 2.92 (0.44–19.31)
Othersb 11 (7.9%) 4 (2.7%) 1.00 1.00
Work experience
<5 years 98 (70.0%) 117 (80.1%) 1.73 (1.00–2.98)∗ 0.51 (0.22–1.18)
≥5 years 42 (30.0%) 29 (19.9%) 1.00 1.00
Department
Surgery 15 (10.7%) 20 (13.7%) 2.833 (0.968–8.297) 1.20 (0.29–5.07)
Laboratory 22 (15.7%) 6 (4.1%) 0.580 (0.169–1.989) 1.35 (0.31–14.41)
Delivery unit 11 (7.9%) 16 (11.0%) 3.091 (0.990–9.647) 1.68 (0.36–7.84)
Emergency 8 (5.7%) 7 (4.8%) 1.859 (0.498–6.941) 1.11 (0.21–5.98)
Internal medicine 35 (25.0%) 40 (27.4%) 2.429 (0.935–6.311) 0.70 (0.19–2.57)
Pediatrics 16 (11.4%) 37 (25.3%) 4.914 (1.764–13.692)∗ 1.76 (0.44–7.03)
Pharmacy 9 (6.4%) 6 (4.1%) 1.417 (0.374–5.365) 0.36 (0.06–2.29)
Gyn./obs. 7 (5.0%) 6 (4.1%) 1.821 (0.460–7.216) 0.52 (0.09–3.05)
Othersc 17 (12.1%) 8 (5.5%) 1.00 1.00
aCatholic, atheist, and Hindu; bhealth officer, anesthesia, dentist, and physiotherapies; cdental department, oncology, optometry, psychiatry ward, recovery
ward, and general ward. ∗ indicates statistically significant value.
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Table 5: Factors associated with the completion of full course HBV vaccination among health professionals who took at least 1 dose of the
vaccine in GUH, Ethiopia, 2016.
Characteristics Yes (%) No (%) COR (95% CI) AOR (95% CI)
Sex
Male 39 (47.6%) 35 (60.3%) 1.68 (0.85–3.32) 1.61 (0.65–4.03)
Female 43 (52.4%) 23 (39.7%) 1.00 1.00
Age (yrs)
21–29 65 (79.3%) 42 (72.4%) 0.32 (0.03–3.68) 0.53 (0.03–8.86)
30–39 16 (19.5%) 14 (24.1%) 0.44 (0.04–5.36) 0.73 (0.04–12.53)
>40 1 (1.2%) 2 (3.4%) 1.00 1.00
Religion
Orthodox 70 (85.4%) 39 (67.2%) 0.28 (0.02–3.17) 0.54 (0.03–11.04)
Muslim 9 (11.0%) 7 (12.1%) 0.39 (0.03–5.21) 0.44 (0.02–10.28)
Protestant 2 (2.4%) 10 (17.2%) 2.50 (0.15–42.80) 7.59 (0.25–231.59)
Othersa 1 (1.2%) 2 (3.4%) 1.00 1.00
Marital status
Unmarried 40 (48.8%) 32 (55.2%) 1.29 (0.66–2.54) 1.46 (0.56–3.83)
Married 42 (51.2%) 26 (44.8%) 1.00 1.00
Education level
Certificate 2 (2.4%) 2 (3.4%) 0.67 (0.05–9.47) 2.36 (0.06–86.69)
Diploma 2 (2.4%) 2 (3.4%) 0.67 (0.05–9.47) 7.57 (0.19–301.00)
First degree 67 (81.7%) 47 (81.0%) 0.47 (0.08–2.91) 1.86 (0.11–31.12)
Master degree 9 (11.0%) 4 (6.9%) 0.30 (0.04–2.52) 0.60 (0.03–13.60)
Specialist 2 (2.4%) 3 (5.2%) 1.00 1.00
Profession
Medical doctor 7 (8.5%) 8 (13.8%) 0.65 (0.13–3.21) 0.31 (0.03–3.17)
Nurse 38 (46.3%) 24 (41.4%) 0.36 (0.10–1.37) 0.31 (0.05–2.13)
Health officer 2 (2.4%) 2 (3.4%) 0.57 (0.06–5.78) 0.23 (0.01–4.50)
Pharmacist 6 (7.3%) 9 (15.5%) 0.86 (0.17–4.27) 1.87 (0.16–22.11)
Lab. technologist 18 (22.0%) 4 (6.9%) 0.13 (0.03–0.65) 0.08 (0.01–0.63)∗
Midwifes 7 (8.5%) 4 (6.9%) 0.33 (0.06–1.86) 0.71 (0.06–9.05)
Othersb 4 (4.9%) 7 (12.1%) 1.00 1.00
Work experience
<5 years 59 (72.0%) 39 (70.0%) 0.80 (0.39–1.66) 0.71 (0.25–2.04)
≥5 years 23 (28.0%) 42 (30.0%) 1.00 1.00
Department
Surgery 8 (9.8%) 7 (12.1%) 0.98 (0.25–3.96) 0.98 (0.17–5.71)
Laboratory 18 (22%) 4 (6.9%) 0.25 (0.06–1.06) 0.47 (0.06–3.92)
Delivery 7 (8.5%) 4 (6.9%) 0.64 (0.14–3.04) 0.19 (0.02–2.27)
Emergency 4 (4.9%) 4 (6.9%) 1.13 (0.21–6.05) 0.71 (0.08–6.61)
Internal medicine 16 (19.5%) 19 (32.8%) 1.34 (0.42–4.27) 1.06 (0.23–4.92)
Pediatrics 10 (12.2%) 6 (10.3%) 0.68 (0.17–2.71) 0.84 (0.15–4.85)
Pharmacy 6 (7.3%) 3 (5.2%) 0.56 (0.11–3.02) 0.10 (0.01–1.77)
Gynecology/obstetrics 4 (4.9%) 3 (5.2%) 0.84 (0.14–4.97) 0.55 (0.06–5.21)
Othersc 9 (11.0%) 8 (13.8%) 1.00 1.00
aCatholic, atheist, and Hindu; bhealth officer, anesthesia, dentist, and physiotherapies; cdental department, oncology, optometry, psychiatry ward, recovery
ward, and general ward. ∗ indicates statistically significant value.
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